346 related articles for article (PubMed ID: 9916717)
1. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
Large MK; Kittlesen DJ; Hahn YS
J Immunol; 1999 Jan; 162(2):931-8. PubMed ID: 9916717
[TBL] [Abstract][Full Text] [Related]
2. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
[TBL] [Abstract][Full Text] [Related]
3. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids.
Geissler M; Gesien A; Wands JR
J Immunol; 1997 Nov; 159(10):5107-13. PubMed ID: 9366440
[TBL] [Abstract][Full Text] [Related]
5. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
6. Lethality in mice infected with recombinant vaccinia virus expressing hepatitis C virus core protein.
Zhang H
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):374-82. PubMed ID: 14599943
[TBL] [Abstract][Full Text] [Related]
7. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence.
Moorman JP; Joo M; Hahn YS
Arch Immunol Ther Exp (Warsz); 2001; 49(3):189-94. PubMed ID: 11478392
[TBL] [Abstract][Full Text] [Related]
8. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
Kamei A; Tamaki S; Taniyama H; Takamura S; Nishimura Y; Kagawa Y; Uno-Furuta S; Kaito M; Kim G; Toda M; Matsuura Y; Miyamura T; Adachi Y; Yasutomi Y
Virology; 2000 Jul; 273(1):120-6. PubMed ID: 10891414
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
Geissler M; Gesien A; Tokushige K; Wands JR
J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964
[TBL] [Abstract][Full Text] [Related]
10. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
11. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
12. Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide.
Lasarte JJ; Corrales FJ; Casares N; López-Díaz de Cerio A; Qian C; Xie X; Borrás-Cuesta F; Prieto J
J Immunol; 1999 May; 162(9):5270-7. PubMed ID: 10228002
[TBL] [Abstract][Full Text] [Related]
13. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
Pancholi P; Liu Q; Tricoche N; Zhang P; Perkus ME; Prince AM
J Infect Dis; 2000 Jul; 182(1):18-27. PubMed ID: 10882577
[TBL] [Abstract][Full Text] [Related]
14. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.
Haller AA; Lauer GM; King TH; Kemmler C; Fiolkoski V; Lu Y; Bellgrau D; Rodell TC; Apelian D; Franzusoff A; Duke RC
Vaccine; 2007 Feb; 25(8):1452-63. PubMed ID: 17098335
[TBL] [Abstract][Full Text] [Related]
15. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
Nelson DR; Marousis CG; Davis GL; Rice CM; Wong J; Houghton M; Lau JY
J Immunol; 1997 Feb; 158(3):1473-81. PubMed ID: 9013994
[TBL] [Abstract][Full Text] [Related]
16. [Expression and immune response to hepatitis C virus core gene combined hepatitis B virus core gene with two multiple cloning sites vector].
Deng T; Fan G; Chen T; Chen N; Hu D; Wang M; Jia K
Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):77-80. PubMed ID: 11953132
[TBL] [Abstract][Full Text] [Related]
17. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
[TBL] [Abstract][Full Text] [Related]
18. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
[TBL] [Abstract][Full Text] [Related]
19. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains.
Andersson HA; Singh RA; Barry MA
Mol Ther; 2006 Feb; 13(2):338-46. PubMed ID: 16242998
[TBL] [Abstract][Full Text] [Related]
20. Recombinant in vitro assembled hepatitis C virus core particles induce strong specific immunity enhanced by formulation with an oil-based adjuvant.
Acosta-Rivero N; Poutou J; Alvarez-Lajonchere L; Guerra I; Aguilera Y; Musacchio A; Rodríguez A; Aguilar JC; Falcon V; Alvarez-Obregon JC; Soria Y; Torres D; Linares M; Pérez A; Morales-Grillo J; Dueñas-Carrera S
Biol Res; 2009; 42(1):41-56. PubMed ID: 19621132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
